$0.7699
0.0574[8.06%]
At close: Apr 18
$0.7699
0[0.00%]
After Hours: 7:58PM EDT
Aptevo Therapeutics
(NASDAQ:APVO)Aptevo Therapeutics Stock (NASDAQ:APVO), Analyst Ratings, Price Targets, Predictions
Aptevo Therapeutics Inc has a consensus price target of $35, established from looking at the 2 latest analyst ratings. The last 2 analyst ratings were released from Piper Sandler and Roth Capital on May 13, 2022 and May 28, 2021. With an average price target of $35 between Piper Sandler and Roth Capital, there's an implied 4446.04% upside for Aptevo Therapeutics Inc from these 2 analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
Roth Capital
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Aptevo Therapeutics
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/13/2022 | APVO | Buy Now | Aptevo Therapeutics | $0.77 | 2497.74% | Piper Sandler | Edward Tenthoff | $3036 → $880 | Maintains | Overweight | Get Alert |
| 05/28/2021 | APVO | Buy Now | Aptevo Therapeutics | $0.77 | 6394.35% | Roth Capital | Jonathan Aschoff | $2816 → $2200 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Aptevo Therapeutics (APVO)?
The latest price target for Aptevo Therapeutics (NASDAQ: APVO) was reported by Piper Sandler on May 13, 2022. The analyst firm set a price target for $20.00 expecting APVO to rise to within 12 months (a possible 2497.74% upside). 0 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aptevo Therapeutics (APVO)?
The latest analyst rating for Aptevo Therapeutics (NASDAQ: APVO) was provided by Piper Sandler, and Aptevo Therapeutics maintained their overweight rating.
When was the last upgrade for Aptevo Therapeutics (APVO)?
There is no last upgrade for Aptevo Therapeutics.
When was the last downgrade for Aptevo Therapeutics (APVO)?
There is no last downgrade for Aptevo Therapeutics.
When is the next analyst rating going to be posted or updated for Aptevo Therapeutics (APVO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aptevo Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aptevo Therapeutics was filed on May 13, 2022 so you should expect the next rating to be made available sometime around May 13, 2023.
Is the Analyst Rating Aptevo Therapeutics (APVO) correct?
While ratings are subjective and will change, the latest Aptevo Therapeutics (APVO) rating was a maintained with a price target of $69.00 to $20.00. The current price Aptevo Therapeutics (APVO) is trading at is $0.77, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.